Qiagen N.V. (AERO B) - Medical Equipment - Deals and Alliances Profile

Date: May 5, 2014
Pages: 113
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: Q5A567B2F0EEN
Leaflet:

Download PDF Leaflet

Qiagen N.V. (AERO B) - Medical Equipment - Deals and Alliances Profile
Summary

Qiagen N.V. (Qiagen) is a healthcare company. It provides extensive products services such as automated solutions, isolation analysis, data interpretation systems, reagents,accessories and labware, and sample and assay technologies to study the molecular information of biological material. Its sample technologies help isolate and process proteins, DNA and RNA from biological samples such as blood or tissue; and assay technologies facilitate the development of isolated biomolecules such as the DNA of a specific virus for later analysis. The company has over 500 products that include consumable products, automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification, besides open and target specific assays. Qiagen also supplies diagnostic test kits and assays for human and veterinary molecular diagnostics. The company caters to animal pathogens and genotyping, cancer research, drug development, environmental water testing, human identity & forensic testing, microbiology research, among other areas The company operates in more than 100 countries and sells its products to pharmaceutical and biotechnology companies and research institutions. Qiagen is headquartered in Venlo, the Netherlands.

The company intends to enter into Next Generation Sequencing market. To this end, it is developing next-generation benchtop sequencer with its subsidiary, Intelligent Bio-Systems, Inc.

Qiagen N.V. (AERO B) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Qiagen N.V., Medical Equipment, Deals By Year, 2008 to YTD 2014
Qiagen N.V., Medical Equipment Deals By Type, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Region, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Market, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals Summary, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deal Details
Asset Purchase
QIAGEN Completes Acquisition Of Molecular Diagnostics Distribution Business
QIAGEN Completes Acquisition Of Distribution Business From Diagnostic Technology
Venture Financing
Exosome Diagnostics Raises US$27 Million In Series B Financing Round
Drug Response Dx Raises Funds Through First Round Of Venture Financing
Xagenic Raises US$10 Million In Series A Venture Financing
Ingenuity Systems Secures US$15.4 Million In Financing Round
Partnerships
Qiagen Enters Into Licensing Agreement With CeMM For Calreticulin Biomarker
Qiagen Enters Into Option For Licensing Agreement With Columbia University For FGFR-TACC Fusion Genes
Qiagen Enters Into Option For Licensing Agreement With BC Cancer For EZH2 Y641 Mutation Biomarker
IntelligentMDx Enters Into Licensing Agreement with Qiagen To Develop Molecular Tests
Qiagen Enters Into Licensing Agreement With Drug Response Dx For Rheumatoid Arthritis Biomarkers
Qiagen Enters Into Licensing Agreement With Insight Genetics For Lung Cancer Biomarkers
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications
QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics
Orion Genomics Enters Into Licensing Agreement With QIAGEN
Mayo Medical Labs Enters Into Licensing Agreement With Qiagen
Epigenomics Announces Option Licensing Agreement With QIAGEN
Epigenomics Enters Into Research Licensing Agreement With QIAGEN
Roche Enters Into Licensing Agreement With QIAGEN
QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
QIAGEN Enters Into An Agreement With Roche And Idaho Technology
HandyLab Enters Into An Agreement With Qiagen
Corbett Life Science Enters Into Licensing Agreement With Applied Biosystems Group
Maverix Biomics Extends Co-Marketing Agreement With Qiagen
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test
Maverix Biomics Enters Into Co-Marketing Agreement With Qiagen
Clovis Oncology Enters Into Co-Development Agreement With Qiagen
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits
Qiagen Forms Joint Venture With BioBay To Establish Translational Medicine Center
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools
Ingenuity Systems Enters Into Agreement With GeneInsight To Deliver Integrated Workflow Solution To Clinical Labs
Qiagen Enters Into Co-Development Agreement With Eli Lilly
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit
Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology
Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions
Qiagen Enters Into Co-Marketing Agreement With Lepu Medical
Cardinal Health Enters Into Distribution Agreement With Qiagen For Molecular Diagnostic Products
Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
QIAGEN Enters Into Co-Development Agreement With Insight Genetics
QIAGEN Enters Into Co-Development Agreement With Max Planck Institute
QIAGEN Enters Into Co-Development Agreement With Eli Lilly
Qiagen Enters Into Co-Development Agreement With Pfizer
Olerup Enters Into Co-Marketing Agreement With QIAGEN
EyeSense Enters Into An Agreement With QIAGEN
QIAGEN Enters Into An Agreement With Abbott
QIAGEN Enters Into An Agreement With Genome Diagnostics
QIAGEN Enters Into Distribution Agreement With Roche Molecular Systems
QIAGEN Enters Into Distribution Agreement With Celera
Center for Molecular Medicine Enters Into Research Agreement With QIAGEN
Biosearch Technologies Enters Into An Agreement With QIAGEN
QIAGEN Enters Into Licensing Agreement With BioHelix
Equity Offering
QIAGEN Completes Private Placement Of Its Common Stock For US$640 Million
Debt Offering
Qiagen Completes Public Offering Of Senior Notes Due 2019 For US$430 Million
Qiagen Completes Public Offering Of Senior Notes Due 2021 For US$300 Million
Asset Transactions
Diatherix Labs Acquires Tem-PCR Patent From Qiagen
Acquisition
Qiagen Acquires CLC bio, Bioinformatics Software Company
Qiagen Acquires AmniSure International, Manufacturer Of Non Invasive Test Solutions
Qiagen Completes Acquisition Of Additional 26.7% Stake In Ipsogen For US$30 Million
Qiagen Completes Acquisition Of Cellestis
QIAGEN Completes Acquisition Of ESE
QIAGEN Completes Acquisition Of SABiosciences
QIAGEN Completes Acquisition Of DxS
QIAGEN Completes Acquisition Of Explera
QIAGEN Acquires Corbett Life Science
Qiagen N.V. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Mar 22, 2014: Qiagen Marseille Reports 2012 Annual Results
Jan 29, 2014: QIAGEN Reports Fourth Quarter and Full-Year 2012 Results
Oct 29, 2013: QIAGEN Reports Third Quarter 2013 Results
Oct 09, 2013: QIAGEN to Announce Third Quarter 2013 Financial Results
Jul 30, 2013: QIAGEN Reports Second Quarter 2013 Results and Announces New Share Repurchase Program
Jul 16, 2013: QIAGEN N.V. to Announce Second Quarter 2013 Financial Results
Apr 29, 2013: Qiagen Reports Revenue Of $303.6m In Q1 2013
Jan 29, 2013: Qiagen Reports Revenue Of $1.3 Billion In 2012
Government and Public Interest
Jan 29, 2014: QIAGEN Seeks U.S. Regulatory Clearance for Full QIAsymphony RGQ MDx Workflow and Announces Submission of First Assay of its HAI Portfolio
Product News
Feb 26, 2014: Qiagen Introduces New HPV Test In India
Jan 29, 2014: IMDx Designs, Develops and Manufactures CE-Marked artus C. difficile QS-RGQ Kit for use with QIAsymphony SP/AS and Rotor-Gene Q instruments
Jan 29, 2014: QIAGEN Seeks U.S. Regulatory Clearance for Full QIAsymphony RGQ MDx Workflow and Announces Submission of First Assay of its HAI Portfolio
Oct 25, 2013: LabCorp to Offer New FDA-Approved Companion Diagnostic for Colorectal Cancer
Jul 12, 2013: QIAGEN receives FDA approval for therascreen EGFR RGQ PCR Kit as a companion diagnostic for lung cancer patients
Apr 02, 2013: Insight Genetics And NCI Collaborate To Develop New Technologies For Clinical Trials
Mar 30, 2013: QIAGEN announces commercial launch of careHPV Test in China
Jan 30, 2013: Clarient Adopts Qiagen's KRAS Companion Diagnostic For Colorectal Cancer
Jan 15, 2013: Qiagen Submits therascreen EGFR RGQ PCR Kit To FDA To Guide Treatment Decisions For New Investigational Lung Cancer Compound
Product Approvals
Jan 29, 2014: IMDx Designs, Develops and Manufactures CE-Marked artus C. difficile QS-RGQ Kit for use with QIAsymphony SP/AS and Rotor-Gene Q instruments
Jul 12, 2013: QIAGEN receives FDA approval for therascreen EGFR RGQ PCR Kit as a companion diagnostic for lung cancer patients
Other Significant Developments
Jan 18, 2014: Trinean to enter into global supply agreement with QIAGEN
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Qiagen N.V., Medical Equipment, Key Facts, 2013
Qiagen N.V., Medical Equipment, Deals By Year, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Region, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Market, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals Summary, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Year, 2008 to YTD 2014
Qiagen N.V., Medical Equipment Deals By Type, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Region, 2008 to YTD 2014
Qiagen N.V., Deals By Market, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals Summary, 2008 to YTD 2014
QIAGEN Completes Acquisition Of Molecular Diagnostics Distribution Business
QIAGEN Completes Acquisition Of Distribution Business From Diagnostic Technology
Exosome Diagnostics Raises US$27 Million In Series B Financing Round
Drug Response Dx Raises Funds Through First Round Of Venture Financing
Xagenic Raises US$10 Million In Series A Venture Financing
Ingenuity Systems Secures US$15.4 Million In Financing Round
Qiagen Enters Into Licensing Agreement With CeMM For Calreticulin Biomarker
Qiagen Enters Into Option For Licensing Agreement With Columbia University For FGFR-TACC Fusion Genes
Qiagen Enters Into Option For Licensing Agreement With BC Cancer For EZH2 Y641 Mutation Biomarker
IntelligentMDx Enters Into Licensing Agreement with Qiagen To Develop Molecular Tests
Qiagen Enters Into Licensing Agreement With Drug Response Dx For Rheumatoid Arthritis Biomarkers
Qiagen Enters Into Licensing Agreement With Insight Genetics For Lung Cancer Biomarkers
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications
QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics
Orion Genomics Enters Into Licensing Agreement With QIAGEN
Mayo Medical Labs Enters Into Licensing Agreement With Qiagen
Epigenomics Announces Option Licensing Agreement With QIAGEN
Epigenomics Enters Into Research Licensing Agreement With QIAGEN
Roche Enters Into Licensing Agreement With QIAGEN
QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
QIAGEN Enters Into An Agreement With Roche And Idaho Technology
HandyLab Enters Into An Agreement With Qiagen
Corbett Life Science Enters Into Licensing Agreement With Applied Biosystems Group
Maverix Biomics Extends Co-Marketing Agreement With Qiagen
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test
Maverix Biomics Enters Into Co-Marketing Agreement With Qiagen
Clovis Oncology Enters Into Co-Development Agreement With Qiagen
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits
Qiagen Forms Joint Venture With BioBay To Establish Translational Medicine Center
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools
Ingenuity Systems Enters Into Agreement With GeneInsight To Deliver Integrated Workflow Solution To Clinical Labs
Qiagen Enters Into Co-Development Agreement With Eli Lilly
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit
Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology
Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions
Qiagen Enters Into Co-Marketing Agreement With Lepu Medical
Cardinal Health Enters Into Distribution Agreement With Qiagen For Molecular Diagnostic Products
Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
QIAGEN Enters Into Co-Development Agreement With Insight Genetics
QIAGEN Enters Into Co-Development Agreement With Max Planck Institute
QIAGEN Enters Into Co-Development Agreement With Eli Lilly
Qiagen Enters Into Co-Development Agreement With Pfizer
Olerup Enters Into Co-Marketing Agreement With QIAGEN
EyeSense Enters Into An Agreement With QIAGEN
QIAGEN Enters Into An Agreement With Abbott
QIAGEN Enters Into An Agreement With Genome Diagnostics
QIAGEN Enters Into Distribution Agreement With Roche Molecular Systems
QIAGEN Enters Into Distribution Agreement With Celera
Center for Molecular Medicine Enters Into Research Agreement With QIAGEN
Biosearch Technologies Enters Into An Agreement With QIAGEN
QIAGEN Enters Into Licensing Agreement With BioHelix
QIAGEN Completes Private Placement Of Its Common Stock For US$640 Million
Qiagen Completes Public Offering Of Senior Notes Due 2019 For US$430 Million
Qiagen Completes Public Offering Of Senior Notes Due 2021 For US$300 Million
Diatherix Labs Acquires Tem-PCR Patent From Qiagen
Qiagen Acquires CLC bio, Bioinformatics Software Company
Qiagen Acquires AmniSure International, Manufacturer Of Non Invasive Test Solutions
Qiagen Completes Acquisition Of Additional 26.7% Stake In Ipsogen For US$30 Million
Qiagen Completes Acquisition Of Cellestis
QIAGEN Completes Acquisition Of ESE
QIAGEN Completes Acquisition Of SABiosciences
QIAGEN Completes Acquisition Of DxS
QIAGEN Completes Acquisition Of Explera
QIAGEN Acquires Corbett Life Science
Qiagen N.V., Key Competitors
Qiagen N.V., Key Employees
Qiagen N.V., Subsidiaries

LIST OF FIGURES

Qiagen N.V., Medical Equipment, Deals by Type, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Year, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals by Type, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals By Region, 2008 to YTD 2014
Qiagen N.V., Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

Qiagen N.V. (AERO B) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: